Patent · US Active

Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof

US7795409B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignees

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB
Cornell Research Foundation, Inc. · US

Inventors

Dirk Jager · New York, US
Elisabeth Stockert · New York, US
Matthew Scanlan · Princeton Junction, US
Ali Gure · New York, US
Elke Jager · Frankfurt am Main, DE
Alexander Knuth · Frankfurt am Main, DE
Lloyd J. Old · New York, US
Yao-Tseng Chen · New York, US

Key dates

Filing date	Jan 30, 2008
Grant date	Sep 14, 2010
Priority date	—
Expiry date	Jun 7, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/4748
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.